Recent Posts
- Approval Advances Psilocybin Treatment Plans in Canada
- Oral NNI-351 Awarded Orphan Drug Status by FDA
- NNI-351 Earns Rare Pediatric Disease Designation From FDA
- FMR1 Gene Renamed to Increase Accuracy and Remove Stigmatizing Language
- Study Supports Development of Preventive Treatments for FXTAS
- Organizations Rally to Help Ukrainian Rare Disease Patients
- Low Cholesterol in Cells’ Lipid Rafts May Add to Behavioral Differences
- Europe Awaits Proposed New Framework for Sharing Health Data
- Telehealth Added to Latest Digital-friendly NORD State Report Card
- Lovastatin, Minocycline Combined Helps Fragile X Behavior, Caregivers Report